Approved for COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COMIRNATY is approved for use in individuals who are: • 65 years of age and older, or • 5 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes…
Loading full data from Know Your Drugs Institute…